Search details
1.
First-in-human study of E7130 (a tumor microenvironment-ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose-escalation part.
Cancer
; 129(15): 2348-2359, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-37080942
2.
A phase I pharmacokinetic study of lenvatinib in Chinese patients with unresectable hepatocellular carcinoma.
Future Oncol
; 18(22): 2413-2424, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35674480
3.
Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma.
Cancer Sci
; 112(3): 1123-1131, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33492746
4.
Pharmacokinetic study of lenvatinib in Chinese patients with solid tumors.
Future Oncol
; 17(15): 1855-1863, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33474967
5.
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects.
Int J Clin Pharmacol Ther
; 58(12): 757-764, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32870153
6.
A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects.
Clin Drug Investig
; 43(3): 155-165, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36746851
7.
Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects.
Clin Pharmacol Drug Dev
; 7(6): 613-620, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29870595
Results
1 -
7
de 7
1
Next >
>>